Goals: Pembele 18 ‘, Mbappe 79’, Gueye 88 ‘, Kean 90’ + 1.

Things got worse for Thomas Tuchel since mid-December, when PSG had problems with both force and performance. In a difficult situation, the German teacher was forced to use a young player. One of them – Timothee Pembele opened the score on the night of December 23. The 18-year-old winger stormed the wall after the ball was thrown from the Strasbourg goalkeeper.

Excellent ball control (69%), twice as many shots (17 vs. 8), but PSG had to wait until the end of the game to get more goals. In the 79th minute, Kylian Mbappe extinguished the visitors’ hopes for points with a close-up ball, after a cross from Di Maria. This is Mbappe’s 12th goal in Ligue 1 this season, two more than the second in the list of top scorer Boulaye Dia.

Mbappe is a rare PSG player who has kept the past time. He scored twice against Istanbul Basaksehir in the Champions League, and scored two more goals in the last five Ligue 1 rounds. Thanks to the goals of the French striker, PSG avoids the scenario of a chain collapse, similar to earlier in the season.

Before that, PSG did not win against both champions. They hung their shirts at home in front of Lyon, and lost their main striker Neymar. A week later, it was Lille’s turn to draw PSG, pushing the Paris team down to third. Tuchel’s side also lost three more players in the defense, center-back Presnel Kimpembe, and two full-backs Kurzawa and Florenzi.

In addition to the previous injuries of Mauro Icardi, Pablo Sarabia, Juan Bernat, PSG had to wait until two reserve players Idrissa Gueye and Moise Kean to secure a 4-0 victory over Strasbourg – a team that was struggling to stay relegated. However, the Paris team did not improve their position because the two above-ranked teams, Lille and Lyon, both won this round.

Winning back after a series of three declines in form, but PSG has much to do. In the immediate future is the liquidation of less-used players such as Julian Draxler, Leandro Paredes to reduce the budget deficit due to Covid-19.